Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12839]

FDA aproves pomalidomide for multiple myeloma where two prior therapies have failed

FDA aproves pomalidomide for multiple myeloma where two prior therapies have failed

Most NCDs could be treated with small number of cheap generic drugs and within existing budgets

Most NCDs could be treated with small number of cheap generic drugs and within existing budgets

Addressing social and economic inequalities among disadvantaged groups vital to tackling NCDs

Addressing social and economic inequalities among disadvantaged groups vital to tackling NCDs

Implementing three cost-effective interventions could rapidly reduce NCD death and disability rates in all countries

Implementing three cost-effective interventions could rapidly reduce NCD death and disability rates in all...

Two drugs better one to treat most deadly skin cancer

Two drugs better one to treat most deadly skin cancer

First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment

First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment

DAI provides potential imaging biomarker to indicate brain tumor response to radiation therapy

DAI provides potential imaging biomarker to indicate brain tumor response to radiation therapy

SUVmax provides valuable indicator of progression-free survival in stage I NSCLC patients

SUVmax provides valuable indicator of progression-free survival in stage I NSCLC patients

Hepatic function testing can assist in treatment planning for liver cancer patients

Hepatic function testing can assist in treatment planning for liver cancer patients

CT texture analysis of tumours may be a valuable biomarker in localised oesophageal cancer

CT texture analysis of tumours may be a valuable biomarker in localised oesophageal cancer

More from ecancer